The Hepatic Stellate Cells (HSTCs) and Adipose-derived Mesenchymal Stem Cells (ASCs) Axis as a Potential Major Driver of Metabolic Syndrome - Novel Concept and Therapeutic Implications

Stem Cell Rev Rep. 2022 Apr;18(4):1417-1422. doi: 10.1007/s12015-021-10304-w. Epub 2021 Nov 25.

Abstract

Herein, we would like to introduce a novel concept for the prevention and treatment of metabolic syndrome, which is based on molecular relationship between liver and adipose tissue. Particularly, we believe, that unravelling the molecular crosstalk between hepatokines and adipokines will allow to better understand the pathophysiology of metabolic diseases and allow to develop novel, effective therapeutic solutions against obesity and metabolic syndrome. Inter-organ communication on the level of stem progenitor cells-hepatic stellate cells (HSTCs) and adipose-derived progenitors (ASCs) could represents a key mechanism involved in controlling glucose tolerance as well as insulin sensitivity.

Keywords: A-Reg; ASCs; Adipokines; Crosstalk; HSTCs; Hepatokines; Metabolic syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipokines / metabolism
  • Adipose Tissue / metabolism
  • Hepatic Stellate Cells / metabolism
  • Humans
  • Mesenchymal Stem Cells* / metabolism
  • Metabolic Syndrome* / metabolism
  • Metabolic Syndrome* / therapy

Substances

  • Adipokines